Injectable drug delivery Market Research Report Information by Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer) By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

1 Report Prologue

2 Market Introduction

2.1 Scope of Study 20

2.2 Research Objective 20

2.3 List of Assumptions 20

3 Research Methodology

3.1 Research Process 23

3.2 Primary Research 24

3.3 Secondary Research 25

3.4 Market Size Estimation 26

4 Market Dynamics

4.1 Introduction 28

4.2 Drivers 29

4.2.1 Increasing Prevalence of Chronic Diseases 29

4.2.2 Growing Adoption of Self-Injectable Devices 29

4.2.3 Rising FDA Approvals 29

4.2.4 Drivers Impact Analysis 30

4.3 Restraints 30

4.3.1 Risks of Cross-Contamination 30

4.3.2 Increasing Cost of High-End Products 30

4.3.3 Restraints Impact Analysis 31

4.4 Opportunity 31

4.4.1 Increasing Campaigns of Vaccination in Developing Economies of the Asia-Pacific Region 31

4.5 Macroeconomic Indicators 31

4.6 Market Trend 32

4.6.1 Increasing Use of Auto-Injectors Against Allergies 32

5 Market Factor Analysis

5.1 Value Chain Analysis 34

5.1.1 R&D and Designing 34

5.1.2 Manufacturing 34

5.1.3 Distribution & Sales 34

5.1.4 Post-Sales Review 35

5.2 Porter’s Five Forces Model 35

5.2.1 Threat of New Entrants 35

5.2.2 Bargaining Power of Suppliers 36

5.2.3 Threat of Substitutes 36

5.2.4 Bargaining Power of Buyers 36

5.2.5 Intensity of Rivalry 36

5.3 Investment Opportunities 36

5.4 Pricing Analysis 37

5.5 Demand & Supply: Gap Analysis 37

6 Injectable Drug Delivery Devices Market, by Devices

6.1 Introduction 39

6.2 Conventional Injection Devices 40

6.3 Self-Injection Devices 42

7 Injectable Drug Delivery Devices Market, by Therapeutic Application

7.1 Introduction 44

7.2 Autoimmune Diseases 45

7.3 Hormonal Disorders 45

7.4 Cancer 45

8 Injectable Drug Delivery Devices Market, by Usage Pattern

8.1 Introduction 47

8.2 Curative Pattern 48

8.3 Immunization 48

9 Injectable Drug Delivery Devices Market, by Site of Delivery

9.1 Introduction 50

9.2 Intramuscular 51

9.3 Subcutaneous 51

9.4 Intra Dermal 51

10 Injectable Drug Delivery Devices Market, by Distribution Channel

10.1 Introduction 53

10.2 Hospital & Retail Pharmacies 54

10.3 Online Platforms 54

11 Injectable Drug Delivery Devices Market, by Facility of Use

11.1 Introduction 56

11.2 Hospitals and Clinics 57

11.3 Home Care Settings 57

12 Global Injectable Drug Delivery Devices Market, by Region

12.1 Introduction 59

12.2 Americas 60

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.2.1 North America 63

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.2.1.1 US 66

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.2.1.2 Canada 68

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.2.1.3 South America 71

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3 Europe 74

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1 Western Europe 77

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.1 Germany 80

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.2 UK 83

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.3 France 86

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.4 Italy 88

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.5 Spain 91

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.1.6 Rest of Western Europe 94

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.3.2 Eastern Europe 97

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4 Asia-Pacific 100

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.1 Japan 103

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.2 China 106

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.3 India 108

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.4 South Korea 111

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.5 Australia 114

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.4.6 Rest of Asia-Pacific 117

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.5 Middle East & Africa 120

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.5.1 Middle East 123

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

12.5.2 Africa 126

Injectable Drug Delivery Devices Market, by Devices

Injectable Drug Delivery Devices Market, by Therapeutic Application

Injectable Drug Delivery Devices Market, by Usage Pattern

Injectable Drug Delivery Devices Market, by Site of Delivery

Injectable Drug Delivery Devices Market, by Distribution Channel

Injectable Drug Delivery Devices Market, by Facility of Use

13 Competitive Landscape

13.1 Introduction 130

14 Company Profile

14.1 Eisai Co., Ltd. 132

14.1.1 Company Overview 132

14.1.2 Financial Overview 132

14.1.3 Products Offered 133

14.1.4 Key Developments 133

14.1.5 SWOT Analysis 133

14.1.6 Key Strategies 133

14.2 Antares Pharma 134

14.2.1 Company Overview 134

14.2.2 Financial Overview 134

14.2.3 Products Offered 135

14.2.4 Key Developments 135

14.2.5 SWOT Analysis 135

14.2.6 Key Strategies 135

14.3 AstraZeneca 136

14.3.1 Company Overview 136

14.3.2 Financial Overview 136

14.3.3 Pipeline Products 137

14.3.4 Key Developments 137

14.3.5 SWOT Analysis 137

14.3.6 Key Strategies 137

14.4 Becton, Dickinson and Company 138

14.4.1 Company Overview 138

14.4.2 Financial Overview 138

14.4.3 Products Offered 139

14.4.4 Key Developments 139

14.4.5 SWOT Analysis 140

14.4.6 Key Strategies 140

14.5 Eli Lilly and Company 141

14.5.1 Company Overview 141

14.5.2 Financial Overview 141

14.5.3 Products Offered 142

14.5.4 Key Developments 142

14.5.5 SWOT Analysis 142

14.5.6 Key Strategies 142

14.6 F. Hoffmann-La Roche AG 143

14.6.1 Company Overview 143

14.6.2 Financial Overview 143

14.6.3 Products Offered 144

14.6.4 Key Developments 144

14.6.5 SWOT Analysis 144

14.6.6 Key Strategies 144

14.7 Johnson & Johnson Services Inc. 145

14.7.1 Company Overview 145

14.7.2 Financial Overview 145

14.7.3 Products Offered 146

14.7.4 Key Developments 146

14.7.5 SWOT Analysis 146

14.7.6 Key Strategies 146

14.8 Mylan N.V. 147

14.8.1 Company Overview 147

14.8.2 Financial Overview 147

14.8.3 Products Offered 148

14.8.4 Key Developments 148

14.8.5 SWOT Analysis 148

14.8.6 Key Strategies 148

14.9 Novartis AG 149

14.9.1 Company Overview 149

14.9.2 Financial Overview 149

14.9.3 Products Offered 150

14.9.4 Key Developments 150

14.9.5 SWOT Analysis 150

14.9.6 Key Strategies 150

14.10 Novo Nordisk 151

14.10.1 Company Overview 151

14.10.2 Financial Overview 151

14.10.3 Products Offered 152

14.10.4 Key Developments 152

14.10.5 SWOT Analysis 152

14.10.6 Key Strategies 152

14.11 Pfizer Inc. 153

14.11.1 Company Overview 153

14.11.2 Financial Overview 153

14.11.3 Products Offered 154

14.11.4 Key Developments 154

14.11.5 SWOT Analysis 154

14.11.6 Key Strategies 154

14.12 Sanofi 155

14.12.1 Company Overview 155

14.12.2 Financial Overview 155

14.12.3 Products Offered 156

14.12.4 Key Developments 156

14.12.5 SWOT Analysis 156

14.12.6 Key Strategies 156

14.13 Teva Pharmaceutical Industries Ltd 157

14.13.1 Company Overview 157

14.13.2 Financial Overview 157

14.13.3 Products Offered 158

14.13.4 Key Developments 158

14.13.5 SWOT Analysis 158

14.13.6 Key Strategies 158

14.14 Inovio Pharmaceuticals Inc. 159

14.14.1 Company Overview 159

14.14.2 Financial Overview 159

14.14.3 Products Offered 160

14.14.4 Key Developments 160

14.14.5 SWOT Analysis 160

14.14.6 Key Strategies 160

15 Appendix

15.1 Discussion Blue Print 162

16 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 20

TABLE 2 PRIMARY INTERVIEWS 24

TABLE 3 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 39

TABLE 4 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CONVENTIONAL INJECTION DEVICES BY REGION 2020–2027 (USD MILLION) 40

TABLE 5 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 40

TABLE 6 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 41

TABLE 7 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 41

TABLE 8 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SELF-INJECTION DEVICES BY REGION 2020–2027 (USD MILLION) 42

TABLE 9 GLOBAL SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 42

TABLE 10 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR AUTOIMMUNE DISEASES BY REGION 2020–2027 (USD MILLION) 45

TABLE 12 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HORMONAL DISORDERS BY REGION 2020–2027 (USD MILLION) 45

TABLE 13 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CANCER BY REGION 2020–2027 (USD MILLION) 45

TABLE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 47

TABLE 15 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CURATIVE PATTERN BY REGION 2020–2027 (USD MILLION) 48

TABLE 16 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR IMMUNIZATION BY REGION 2020–2027 (USD MILLION) 48

TABLE 17 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 50

TABLE 18 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRAMUSCULAR BY REGION 2020–2027 (USD MILLION) 51

TABLE 19 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SUBCUTANEOUS BY REGION 2020–2027 (USD MILLION) 51

TABLE 20 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRA DERMAL BY REGION 2020–2027 (USD MILLION) 51

TABLE 21 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 53

TABLE 22 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITAL & RETAIL PHARMACIES BY REGION 2020–2027 (USD MILLION) 54

TABLE 23 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR ONLINE PLATFORMS BY REGION 2020–2027 (USD MILLION) 54

TABLE 24 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 56

TABLE 25 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITALS AND CLINICS BY REGION 2020–2027 (USD MILLION) 57

TABLE 26 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOME CARE SETTINGS BY REGION 2020–2027 (USD MILLION) 57

TABLE 27 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 59

TABLE 28 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 60

TABLE 29 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 60

TABLE 30 AMERICAS SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 61

TABLE 31 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 61

TABLE 32 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 61

TABLE 33 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 61

TABLE 34 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 62

TABLE 35 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 62

TABLE 36 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 62

TABLE 37 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 62

TABLE 38 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 63

TABLE 39 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 63

TABLE 40 NORTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 63

TABLE 41 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 63

TABLE 42 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 64

TABLE 43 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 64

TABLE 44 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 64

TABLE 45 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 64

TABLE 46 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 65

TABLE 47 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 65

TABLE 48 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 65

TABLE 49 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 66

TABLE 50 US SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 66

TABLE 51 US CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 66

TABLE 52 US CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 66

TABLE 53 US CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 67

TABLE 54 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 67

TABLE 55 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 67

TABLE 56 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 67

TABLE 57 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 68

TABLE 58 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 68

TABLE 59 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 68

TABLE 60 CANADA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 68

TABLE 61 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 69

TABLE 62 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 69

TABLE 63 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 69

TABLE 64 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 69

TABLE 65 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 70

TABLE 66 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 70

TABLE 67 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 70

TABLE 68 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 71

TABLE 69 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 71

TABLE 70 SOUTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 71

TABLE 71 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 71

TABLE 72 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 72

TABLE 73 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 72

TABLE 74 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 72

TABLE 75 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 72

TABLE 76 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 73

TABLE 77 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73

TABLE 78 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 73

TABLE 79 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 74

TABLE 80 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 74

TABLE 81 EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 75

TABLE 82 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 75

TABLE 83 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 75

TABLE 84 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 75

TABLE 85 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 76

TABLE 86 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 76

TABLE 87 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 76

TABLE 88 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76

TABLE 89 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 77

TABLE 90 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2020–2027 (USD MILLION) 77

TABLE 91 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 77

TABLE 92 WESTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 78

TABLE 93 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 78

TABLE 94 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 78

TABLE 95 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 78

TABLE 96 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 79

TABLE 97 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 79

TABLE 98 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 79

TABLE 99 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 80

TABLE 100 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 80

TABLE 101 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 80

TABLE 102 GERMANY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 80

TABLE 103 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 81

TABLE 104 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 81

TABLE 105 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 81

TABLE 106 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 81

TABLE 107 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 82

TABLE 108 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 82

TABLE 109 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 82

TABLE 110 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 83

TABLE 111 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 83

TABLE 112 UK SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 83

TABLE 113 UK CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 83

TABLE 114 UK CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 84

TABLE 115 UK CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 84

TABLE 116 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 84

TABLE 117 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 84

TABLE 118 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 85

TABLE 119 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 85

TABLE 120 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 85

TABLE 121 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 86

TABLE 122 FRANCE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 86

TABLE 123 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 86

TABLE 124 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 86

TABLE 125 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 87

TABLE 126 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 87

TABLE 127 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 87

TABLE 128 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 87

TABLE 129 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 88

TABLE 130 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 88

TABLE 131 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 88

TABLE 132 ITALY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 88

TABLE 133 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 89

TABLE 134 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 89

TABLE 135 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 89

TABLE 136 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 89

TABLE 137 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 90

TABLE 138 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 90

TABLE 139 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 90

TABLE 140 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 91

TABLE 141 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 91

TABLE 142 SPAIN SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 91

TABLE 143 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 91

TABLE 144 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 92

TABLE 145 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 92

TABLE 146 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 92

TABLE 147 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 92

TABLE 148 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 93

TABLE 149 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 93

TABLE 150 SPAIN INJECTABLE